Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19

Lancet Infect Dis. 2022 May;22(5):567-569. doi: 10.1016/S1473-3099(21)00762-3. Epub 2021 Dec 23.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents, Immunological*
  • COVID-19*
  • Hospitalization
  • Humans
  • SARS-CoV-2

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents, Immunological